| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Feb 20, 2025 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 95.0 | +1,363,636 | 4.54% | ✗ | $15M |
| Dec 19, 2024 | Dec 23, 2024 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 100.0 | +940,499 | 74.12% | ✗ | $20.1M |
| Dec 18, 2024 | Dec 19, 2024 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 100.0 | +1,759,978 | 23.96% | ✗ | $1.8M |
| Apr 2, 2024 | Apr 3, 2024 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 92.5 | +485,250 | 7.07% | ✗ | $368.8K |
| Feb 12, 2024 | Feb 13, 2024 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 100.0 | +910,000 | 28.29% | ✗ | $20M |
| Jan 29, 2024 | Jan 31, 2024 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 100.0 | +15,238,095 | 102.80% | ✗ | $320M |
| Jun 28, 2023 | Jun 30, 2023 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 97.5 | +1,010,000 | 7.31% | ✗ | $19.5M |
| Jun 27, 2023 | Jun 28, 2023 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 100.0 | +2,930,870 | 21.39% | ✗ | $11M |
| Jan 31, 2021 | Feb 2, 2021 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 100.0 | +5,650,000 | 68.38% | ✗ | $220.4M |